首页> 外文期刊>Mycoses: Diagnosis, therapy and prophylaxis of fungal diseases >Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.
【24h】

Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.

机译:在治疗杂色性牛皮癣时,使用氟替咪唑洗发露1%相对于酮康唑洗发露2%。一项随机双盲比较试验。

获取原文
获取原文并翻译 | 示例
           

摘要

Flutrimazole is an imidazole derivative that has been proven to be efficient in superficial skin fungal infections. The aim of this randomised double-blind study was to compare for the first time, the efficiency and safety of flutrimazole 1% shampoo versus ketoconazole 2% shampoo in the treatment of tinea versicolor. Study population consisted of 60 patients with pityriasis versicolor diagnosed clinically and through direct microscopy and culture. Patients were randomly assigned to two groups: one instructed to apply flutrimazole shampoo 1% and one instructed to apply ketoconazole shampoo 2% both on head and body for 14 days. Patients were re-evaluated 14 days after the end of treatment clinically and through direct microscopy and culture. Twenty-one of 26 patients (80.8%) in the ketoconazole and 22 of 29 patients (75.9%) in the flutrimazole group had both visual healing and negative mycological evaluation. Comparison of the response between the two groups with the Yates' corrected chi-square was foundstatistically not significant (chi(2) = 0.19, d.f. = 1, P = 0.91). None of the patients in the two groups reported any adverse effects. Fourteen (53%) patients in the ketoconazole group and 23 (79%) in the flutrimazole group assessed the shampoos as cosmetically acceptable regarding texture, smell and foam properties. Flutrimazole shampoo 1% appears to present efficacy comparable with ketoconazole 2% in the treatment of tinea versicolor.
机译:氟虫唑是一种咪唑衍生物,已被证明可有效治疗浅表皮肤真菌感染。这项随机双盲研究的目的是首次比较氟他莫唑1%洗发水与酮康唑2%洗发水在花斑癣治疗中的有效性和安全性。研究人群包括60例临床上通过直接显微镜检查和培养确诊的杂色性牛皮癣患者。将患者随机分为两组:一组指示使用1%的氟硝唑洗发水,另一组指示在头部和身体上应用2%的酮康唑洗发水,持续14天。临床结束后14天,通过直接显微镜检查和培养对患者进行重新评估。酮康唑中的26例患者中有21例(80.8%),氟他莫唑组的29例患者中有22例(75.9%)的视力恢复和真菌学评估均为阴性。两组之间的反应与耶茨校正后的卡方的比较在统计学上不显着(chi(2)= 0.19,d.f. = 1,P = 0.91)。两组患者均未报告任何不良反应。酮康唑组中有14名(53%)患者,氟他莫唑组中有23名(79%)患者认为洗发剂在质地,气味和泡沫性质方面在化妆品上可接受。氟替咪唑洗发水1%在花斑癣的治疗中似乎具有与酮康唑2%相当的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号